Stocktoria
MESA LABORATORIES INC /CO/ MLAB
Nasdaq · stock · Industrial Instruments For Measurement, Display, and Control · website · IPO 1984-02-29
MESA LABORATORIES INC /CO/ financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.1M | $241.0M | $216.2M | $219.1M | $184.3M | $133.9M | $117.7M | $103.1M | $96.2M | $93.7M |
| Gross profit | $158.3M | $150.9M | $133.2M | $133.7M | $109.1M | $87.0M | $65.4M | $60.9M | $54.6M | $53.2M |
| R&D expense | $20.3M | $19.5M | $19.3M | $20.5M | $15.8M | $10.4M | $6.4M | $3.5M | $3.5M | $4.2M |
| Operating income | $18.5M | $16.3M | -$272.1M | $3.3M | $4.7M | $12.4M | $7.9M | $9.8M | $2.2M | $16.3M |
| Interest expense | — | — | $5.7M | $4.8M | $3.9M | $8.0M | $5.5M | $1.7M | $1.9M | — |
| Income tax | $5.3M | $7.9M | -$21.4M | -$1.3M | $1.7M | -$971,000 | $2.1M | $1.1M | $3.3M | $3.1M |
| Net income | $6.7M | -$2.0M | -$254.2M | $930,000 | $1.9M | $3.3M | — | — | — | — |
| EPS (diluted) | $1.21 | $-0.36 | $-47.20 | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 | $-0.79 | $2.91 |
| Operating cash flow | $42.8M | $46.8M | $44.1M | $28.0M | $39.2M | $37.1M | $27.0M | $30.6M | $25.7M | $17.3M |
| Free cash flow | $39.6M | $42.6M | $41.6M | $23.4M | $34.8M | $35.1M | $25.5M | $29.3M | $22.9M | — |
| Cash & equivalents | $26.9M | $27.3M | $28.2M | $32.9M | $49.3M | $263.9M | $81.4M | $10.2M | $5.5M | $5.8M |
| Inventory | $26.4M | $25.4M | $32.7M | $34.6M | $24.6M | $11.2M | $11.2M | $6.8M | $9.2M | $13.9M |
| Total assets | $427.7M | $433.3M | $446.8M | $661.8M | $707.4M | $601.5M | $409.1M | $156.8M | $164.1M | $171.7M |
| Total liabilities | $241.5M | $273.5M | $301.4M | $268.4M | $313.6M | $195.2M | $189.1M | $45.5M | $64.7M | $73.9M |
| Shareholders' equity | $186.2M | $159.8M | $145.4M | $393.5M | $393.8M | $406.2M | $220.0M | $111.3M | $99.4M | $97.8M |
Growth · year-over-year · Revenue CAGR 11.5%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +3.4% | +11.5% | -1.3% | +18.8% | +37.6% | +13.8% | +14.1% | +7.2% | +2.7% | +10.6% |
| Net income growth | — | — | -27438.3% | -50.3% | -42.9% | — | — | — | — | — |
| EPS growth | — | — | -27864.7% | -51.4% | -45.3% | +56.1% | -78.0% | — | -127.1% | -2.0% |
| Free cash flow growth | -7.0% | +2.4% | +77.3% | -32.6% | -0.8% | +37.6% | -13.0% | +27.8% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.